vs
Side-by-side financial comparison of Arcellx, Inc. (ACLX) and CSP INC (CSPI). Click either name above to swap in a different company.
CSP INC is the larger business by last-quarter revenue ($12.0M vs $8.1M, roughly 1.5× Arcellx, Inc.). CSP INC runs the higher net margin — 0.8% vs -766.0%, a 766.8% gap on every dollar of revenue. On growth, CSP INC posted the faster year-over-year revenue change (-23.2% vs -79.3%). CSP INC produced more free cash flow last quarter ($-3.0M vs $-63.9M). Over the past eight quarters, CSP INC's revenue compounded faster (-6.3% CAGR vs -24.6%).
Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.
CSP Inc. is a U.S.-based technology firm offering cybersecurity solutions, managed IT services, high-performance computing systems, and IT consulting support. It serves enterprises across healthcare, finance, manufacturing, and public sectors in North America and select global markets.
ACLX vs CSPI — Head-to-Head
Income Statement — Q1 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $12.0M |
| Net Profit | $-62.3M | $91.0K |
| Gross Margin | — | 39.3% |
| Operating Margin | -847.6% | -0.9% |
| Net Margin | -766.0% | 0.8% |
| Revenue YoY | -79.3% | -23.2% |
| Net Profit YoY | -765.1% | -80.7% |
| EPS (diluted) | $-1.13 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $12.0M | ||
| Q3 25 | — | $14.5M | ||
| Q2 25 | — | $15.4M | ||
| Q1 25 | $8.1M | $13.1M | ||
| Q4 24 | $15.3M | $15.7M | ||
| Q3 24 | $26.0M | $13.0M | ||
| Q2 24 | $27.4M | $13.1M | ||
| Q1 24 | $39.3M | $13.7M |
| Q4 25 | — | $91.0K | ||
| Q3 25 | — | $-191.0K | ||
| Q2 25 | — | $-264.0K | ||
| Q1 25 | $-62.3M | $-108.0K | ||
| Q4 24 | $-47.1M | $472.0K | ||
| Q3 24 | $-25.9M | $-1.7M | ||
| Q2 24 | $-27.2M | $-185.0K | ||
| Q1 24 | $-7.2M | $1.6M |
| Q4 25 | — | 39.3% | ||
| Q3 25 | — | 36.6% | ||
| Q2 25 | — | 28.8% | ||
| Q1 25 | — | 32.0% | ||
| Q4 24 | — | 29.1% | ||
| Q3 24 | — | 28.4% | ||
| Q2 24 | — | 35.0% | ||
| Q1 24 | — | 47.3% |
| Q4 25 | — | -0.9% | ||
| Q3 25 | — | -3.7% | ||
| Q2 25 | — | -7.9% | ||
| Q1 25 | -847.6% | -7.6% | ||
| Q4 24 | -348.2% | -2.3% | ||
| Q3 24 | -129.1% | -15.7% | ||
| Q2 24 | -127.8% | -5.5% | ||
| Q1 24 | -40.3% | 9.0% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | — | -1.3% | ||
| Q2 25 | — | -1.7% | ||
| Q1 25 | -766.0% | -0.8% | ||
| Q4 24 | -308.4% | 3.0% | ||
| Q3 24 | -99.4% | -12.7% | ||
| Q2 24 | -99.3% | -1.4% | ||
| Q1 24 | -18.3% | 11.6% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | — | $-0.02 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | $-1.13 | $-0.01 | ||
| Q4 24 | $-0.87 | $0.05 | ||
| Q3 24 | $-0.48 | $-0.17 | ||
| Q2 24 | $-0.51 | $-0.02 | ||
| Q1 24 | $-0.14 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $543.3M | $24.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $416.9M | $44.8M |
| Total Assets | $648.1M | $69.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $24.9M | ||
| Q3 25 | — | $27.4M | ||
| Q2 25 | — | $26.3M | ||
| Q1 25 | $543.3M | $29.5M | ||
| Q4 24 | $587.4M | $30.7M | ||
| Q3 24 | $574.3M | $30.6M | ||
| Q2 24 | $516.7M | $28.9M | ||
| Q1 24 | $573.9M | $27.1M |
| Q4 25 | — | $44.8M | ||
| Q3 25 | — | $44.6M | ||
| Q2 25 | — | $47.5M | ||
| Q1 25 | $416.9M | $47.5M | ||
| Q4 24 | $454.8M | $47.5M | ||
| Q3 24 | $483.0M | $47.3M | ||
| Q2 24 | $487.2M | $48.1M | ||
| Q1 24 | $496.6M | $48.2M |
| Q4 25 | — | $69.2M | ||
| Q3 25 | — | $71.2M | ||
| Q2 25 | — | $66.8M | ||
| Q1 25 | $648.1M | $67.1M | ||
| Q4 24 | $711.3M | $67.5M | ||
| Q3 24 | $764.9M | $69.4M | ||
| Q2 24 | $734.3M | $66.8M | ||
| Q1 24 | $779.7M | $64.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.1M | $-2.9M |
| Free Cash FlowOCF − Capex | $-63.9M | $-3.0M |
| FCF MarginFCF / Revenue | -786.4% | -25.1% |
| Capex IntensityCapex / Revenue | 9.6% | 0.9% |
| Cash ConversionOCF / Net Profit | — | -32.04× |
| TTM Free Cash FlowTrailing 4 quarters | $-122.5M | $-2.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-2.9M | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | — | $-3.3M | ||
| Q1 25 | $-63.1M | $1.9M | ||
| Q4 24 | $-46.0M | $1.7M | ||
| Q3 24 | $30.7M | $-1.5M | ||
| Q2 24 | $-36.2M | $2.4M | ||
| Q1 24 | $-31.9M | $1.7M |
| Q4 25 | — | $-3.0M | ||
| Q3 25 | — | $1.7M | ||
| Q2 25 | — | $-3.3M | ||
| Q1 25 | $-63.9M | $1.9M | ||
| Q4 24 | $-47.5M | $1.7M | ||
| Q3 24 | $28.4M | $-1.5M | ||
| Q2 24 | $-39.5M | $2.4M | ||
| Q1 24 | $-38.3M | $1.6M |
| Q4 25 | — | -25.1% | ||
| Q3 25 | — | 11.5% | ||
| Q2 25 | — | -21.7% | ||
| Q1 25 | -786.4% | 14.5% | ||
| Q4 24 | -311.3% | 10.8% | ||
| Q3 24 | 109.2% | -11.7% | ||
| Q2 24 | -144.1% | 17.9% | ||
| Q1 24 | -97.7% | 11.9% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | 9.6% | 0.1% | ||
| Q4 24 | 9.8% | 0.3% | ||
| Q3 24 | 8.8% | 0.1% | ||
| Q2 24 | 11.7% | 0.3% | ||
| Q1 24 | 16.4% | 0.1% |
| Q4 25 | — | -32.04× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.69× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACLX
Segment breakdown not available.
CSPI
| Products | $6.7M | 56% |
| Services | $5.3M | 44% |
